Titulo:
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos.
.
Guardado en:
0121-5426
2538-9513
32
2021-03-08
6
7
http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Liliana Fernández Trujillo - 2020
| id |
metarevistapublica_asoneumocito_revistacolombianadeneumologia_28-article-500 |
|---|---|
| record_format |
ojs |
| spelling |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. Asociación Colombiana de Neumología y Cirugía de Tórax Fernández Trujillo, Liliana 32 1 Núm. 1 , Año 2020 : . Artículo de revista Revista Colombiana de Neumología Journal article Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148-50. doi: 10.1016/j.thromres.2020.04.041. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. doi:10.1007/s00134-020-06062-x. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142(2):184-6. doi: 10.1161/CIRCULATIONAHA.120.047430. Susen S, Tacquard CA, Godon A, Mansour A, Garrigue D, Nguyen P, et al. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. Crit Care. 2020;24:364. doi: 10.1186/s13054-020-03000-7. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762-8. doi: 10.1093/cid/ciaa248. Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and non-hospitalized medical patients. Blood Adv. 2018;2(22):3198-225. doi: https://doi.org/10.1182/bloodadvances.2018022954. Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. Correspondence COVID-19 : consider cytokine storm syndromes and immunosuppression. Lancet. 2020;6736(20):19-20. doi: 10.1016/S0140-6736(20)30628-0. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020;323(15):1499-1500. doi: 10.1001/jama.2020.3633. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4. doi: 10.1111/jth.14830. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4. doi: 10.1016/S0140-6736(20)30628-0. Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503-16. doi: 10.1016/S0140- 6736(13)61048-X. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. doi: 10.1016/j.thromres.2020.04.013. Aikawa N, Shimazaki S, Yamamoto Y, Saito H, Maruyama I, Ohno R, et al. Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial. Shock. 2011;35(4):349-54. doi: 10.1097/SHK.0b013e318204c019. Ejaz A, Ahmed MM, Tasleem A, Rafay Khan Niazi M, Ahsraf MF, Ahmad I, et al. Thromboprophylaxis in Intensive Care Unit patients: a literature review. Cureus. 2018;10(9):e3341. doi: 10.7759/cureus.3341. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, et al. [Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(0):E006. doi: 10.3760/ cma.j.issn.0253-2727.2020.0006. Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9):e017046. doi: 10.1136/bmjopen-2017-017046. Iba T, Gando S, Thachil J. Anticoagulant therapy for sepsisassociated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost. 2014 Jul;12(7):1010-9. doi: 10.1111/jth.12596. So LK, Lau AC, Yam LY, Cheung TM, Poon E, Yung RW, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361(9369):1615-7. doi: 10.1016/s0140-6736(03)13265-5. Stein PD, Kayali F, Olson RE, Milford CE. Pulmonary thromboembolism in Asians/Pacific islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med. 2004;116(7):435-42. doi: 10.1016/j.amjmed.2003.11.020. Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437-44. doi: 10.1160/TH16-08-0620. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9. doi: 10.1111/jth.14817. Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Pathol Pathobiol. 2020. doi: 10.1097/TP.0000000000003412. Gupta N, Zhao Y-Y, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77-83. doi: 10.1016/j.thromres.2019.07.013. Schmitt FCF, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Uhle F, et al. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care. 2019;9(1):19. doi: 10.1186/s13613-019-0499-6. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. doi: 10.1111/jth.14768. Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613-20. doi: 10.1002/art.38690. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2016;3:CD010406. doi: 10.1002/14651858.CD010406.pub2. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9):e343. doi: 10.1371/journal.pmed.0030343. Singh VK, Mishra A, Singh S, Kumar P, Singh M, Jagannath C, et al. Emerging prevention and treatment strategies to control COVID-19. Pathogens. 2020;9(6):E501. doi: 10.3390/pathogens9060501. Text http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/publishedVersion http://purl.org/redcol/resource_type/ARTEDIT http://purl.org/coar/resource_type/c_b239 http://purl.org/coar/resource_type/c_6501 info:eu-repo/semantics/article https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/500/423 Singer BD, Jain M, Budinger S, Wunderink RG. A call for rational intensive care in the era of COVID-19. Am J Respir Cell Mol Biol. 2020;63(1):132-3. doi: 10.1165/rcmb.2020-0151LE. Rojas M, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y,Camacho B, Gallo JE, et al. Convalescent plasma in COVID-19: possible mechanisms of action. Autoimmun Rev. 2020;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Tsai MJ, Yang KY, Chan MC, Kao KC, Wang HC, Perng WC, et al. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care. 2020;10(1):26. doi: 10.1186/s13613-020-0642-4. U.S. Food and Drug Administration [Internet]. Recommendations for investigational COVID-19 convalescent plasma. 2020. Última visita: 13 de abril de 2020. Disponible en: https://www.fda.gov/vaccines-blood-biologics/investigational-newdrug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117(17):9490-6. doi: 10.1073/pnas.2004168117. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582-9. doi: 10.1001/jama.2020.4783. Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo X, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv. 2020. doi: 10.1101/2020.02.10.20021832. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Garraud O, Heshmati F, Pozzetto B, Lefrere F, Girot R, Saillol A, et al. Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow. Transfus Clin Biol. 2016;23(1):39-44. doi: 10.1016/j.tracli.2015.12.003. Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM, et al. Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus. 2016;14(2):152-7. doi: 10.2450/2015.0131-15. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with COVID-19 - Preliminary report. N Engl J Med. 2020:NEJMoa2021436. doi: 10.1056/NEJMoa2021436. Zhou ZG, Xie SM, Zhang J, Zheng F, Jiang DX, Li KY, et al. Short-term moderate-dose corticosteroid plus immunoglobulin effectively reverses COVID-19 patients who have failed low-dose therapy. Preprints. 2020;2020030065. doi:10.20944/preprints202003.0065.v1. Wang Y, Jiang W, He Q, Wang C, Wang B, Zhou P, et al. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. medRxiv. 2020. doi: https://doi.org/10.1101/2020.03.06.20032342. Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020;117(20):10970-5. doi: 10.1073/pnas.2005615117. Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2020;48(2):e98- e106. doi: 10.1097/ccm.0000000000004093. Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):E474-84. doi: https://doi.org/10.1016/S2665-9913(20)30173-9. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. doi: 10.1016/j.ijantimicag.2020.105949. Beigel JH, Tomashek JM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of COVID-19. N Engl J Med. 2020;383(19):1813-26. doi: 10.1056/NEJMoa2007764. John Hopkins University. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE). Disponible en: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 World Health Organization [Internet]. Novel Coronavirus (2019-nCoV) situation report. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/330778/nCoVsitrep02Feb2020-eng.pdf World Health Organization [Internet]. Infecciones por coronavirus. Disponible en: https://www.who.int/csr/disease/coronavirus_infections/es/5. World Health Organization [Internet]. Global surveillance for human infection with coronavirus disease (COVID-19). Última visita: Disponible en: https://www.who.int/publicationsdetail/global-surveillance-for-human-infection-with-novelcoronavirus-(2019-ncov) Organización Panamericana de la Salud [Internet]. Actualización epidemiológica nuevo coronavirus (2019- nCoV). Última visita: 20 de enero de 2020. Disponible en: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=coronavirus-alertas-epidemiologicas&alias=51355-20-de-enero-de-2020-nuevo-coronavirus-ncov-actualizacionepidemiologica-1&Itemid=270&lang=en World Health Organization [Internet]. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019- nCoV in humans. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance/ World Health Organization [Internet]. Novel coronavirus (2019-nCoV). Disponible en: https://apps.who.int/iris/handle/10665/330775 7 6 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Liliana Fernández Trujillo - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0 https://doi.org/10.30789/rcneumologia.v32.n1.2020.500 Zhu N, Zhang D, Wang W, Li X, Yang B, Song I, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33. doi: 10.1056/NEJMoa2001017. 10.30789/rcneumologia.v32.n1.2020.500 https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/500 2538-9513 0121-5426 application/pdf 2021-03-08 2021-03-08 00:00:00 2021-03-08 00:00:00 manejo clínico de la pademia coronavirus SARS-CoV-2 Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit M. A novel coronavirus emerging in China - Key questions for impact assessment. N Engl J Med. 2020;382(8):692- 4. doi: 10.1056/NEJMp2000929. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, china, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207. doi: 10.1056/NEJMoa2001316. Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, et al. Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial. medRxiv. 2020. doi: https://doi.org/10.1101/2020.07.15.20151852. Bai L, Yang D, Wang X, Tong L, Zhu X, Zhong N, et al. Chinese experts’ consensus on the Internet of things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). Clinical eHealth. 2020;3:7-15. doi: https://doi.org/10.1016/j.ceh.2020.03.001. Silva MG, Fonseca F, Souza V, Almeida M, Cardoso G, Brito M, et al. Effect of high vs. low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection. JAMA Netw Open. 2020;3(4):e208857.doi: 10.1001/jamanetworkopen.2020.8857. Cortegiani A, Ingoglia g, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020;57:279-83. doi: https://doi.org/10.1016/j.jcrc.2020.03.005. University of Oxford [Internet]. Statement from the Chief Investigators of the randomised evaluation of COVID-19 therapy (RECOVERY) trial on lopinavir-ritonavir. 2020. Disponible en: https://www.recoverytrial.net/files/lopinavirritonavir-recovery-statement-29062020_final.pdf Infectious Diseases Society of America [Internet]. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Disponible en: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ 35. Jin YH , Cai L , Cheng ZH , Cheng H , Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4. doi: 10.1186/s40779-020-0233-6. Ye Z, Zang Y, Wang Y, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020;30:4381-9. doi: https://doi.org/10.1007/s00330-020-06801-0. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RTPCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642. doi: 10.1148/radiol.2020200642 . Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Am J Roentgenol. 2020;215:87-93. 10.2214/AJR.20.23034. Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. Am J Roentgenol. 2020;215:121-6. 10.2214/AJR.20.22959. British Society of Thoracic Imaging. COVID-19 BSTI imaging database. Disponible en: https://www.bsti.org.uk/training-andeducation/covid-19-bsti-imaging-database/ Simpson S, Kay F, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America expert Consensus Statement on Reporting Chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American Colleges of Radiology, and RSNA. Radiol Cardiothor Imag. 2020;2(2):e200152. doi: https://doi.org/10.1148/ryct.2020200152. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, et al. The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest. 2020;296(1). doi: https://doi.org/10.1016/j.chest.2020.04.003. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. doi: 10.1007/s00134-020-05991-x. Paules C, Marston H, Fauci A. Coronavirus infections – More than just the common cold. JAMA. 2020;323(8):707-8. doi:10.1001/jama.2020.0757. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-81. doi: 10.1016/S2213-2600(20)30079-5. Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTAScore. Front Microbiol. 2019;10:2752. doi: 10.3389/fmicb.2019.02752. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. doi: 10.1016/S0140-6736(20)30566-3. Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis. 2020;71(6). doi: https://doi.org/10.1093/cid/ciaa414. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med. 2020;201(11):1380-8. doi: 10.1164/rccm.202002-0445OC. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi: 10.1056/NEJMoa2002032. Huang C, Wang Y, Li X, Zhao J, Hun Y, Zhang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. doi: 10.1016/S0140-6736(20)30211-7. 17. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. doi: 10.1016/S0140-6736(20)30251-8. Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(5):140-6. doi: 10.15585/mmwr.mm6905e1. Organización Panamericana de la Salud [Internet]. Prevención y control de infecciones asociadas a la atención de la salud recomendaciones básicas. Disponible en: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=guias-5603&alias=47902-recomendaciones-basicas-para-la-prevencion-y-control-de-infecciones-asociadas-a-la-atencion-de-la-salud-1&Itemid=270&lang=es Ministerio de Salud [Internet]. Manual de medidas básicas para el control de infecciones en IPS. Disponible en: https://www.minsalud.gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx. Ministerio de Salud [Internet]. Nuevo coronavirus (nCoV). Disponible en: https://www.minsalud.gov.co/salud/publica/PET/Paginas/Nuevo-Coronavirus-nCoV.aspx Publication |
| institution |
ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Neumología |
| title |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. |
| spellingShingle |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. Fernández Trujillo, Liliana manejo clínico de la pademia coronavirus SARS-CoV-2 |
| title_short |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. |
| title_full |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. |
| title_fullStr |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. |
| title_full_unstemmed |
La crisis de la pandemia por el SARS-CoV-2 desde el punto de vista de los neumólogos. |
| title_sort |
la crisis de la pandemia por el sars-cov-2 desde el punto de vista de los neumólogos. |
| author |
Fernández Trujillo, Liliana |
| author_facet |
Fernández Trujillo, Liliana |
| topic |
manejo clínico de la pademia coronavirus SARS-CoV-2 |
| topic_facet |
manejo clínico de la pademia coronavirus SARS-CoV-2 |
| citationvolume |
32 |
| citationissue |
1 |
| citationedition |
Núm. 1 , Año 2020 : . |
| publisher |
Asociación Colombiana de Neumología y Cirugía de Tórax |
| ispartofjournal |
Revista Colombiana de Neumología |
| source |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/500 |
| language |
|
| format |
Article |
| rights |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Liliana Fernández Trujillo - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_b239 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2021-03-08 |
| date_accessioned |
2021-03-08 00:00:00 |
| date_available |
2021-03-08 00:00:00 |
| url |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/500 |
| url_doi |
https://doi.org/10.30789/rcneumologia.v32.n1.2020.500 |
| issn |
0121-5426 |
| eissn |
2538-9513 |
| doi |
10.30789/rcneumologia.v32.n1.2020.500 |
| citationstartpage |
6 |
| citationendpage |
7 |
| url2_str_mv |
https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/500/423 |
| _version_ |
1818394608952934400 |